Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1992 Feb;51(2):156–159. doi: 10.1136/ard.51.2.156

Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients.

R Cervera 1, J Font 1, C Paré 1, M Azqueta 1, F Pérez-Villa 1, A López-Soto 1, M Ingelmo 1
PMCID: PMC1005649  PMID: 1550395

Abstract

A prospective two dimensional and Doppler echocardiographic study of 70 consecutive patients with systemic lupus erythematosus (SLE) and 40 controls was carried out. Forty patients (57%) were found to have echocardiographic disturbance. Valvular abnormalities were detected in 31 patients (44%) and in only two controls (5%). Mitral valve abnormalities were the most common findings (23/70 (33%)) with mild or moderate regurgitation the most frequent lesion (16% and 9% respectively). Three patients (4%) had a morphological echocardiographic pattern suggestive of non-infective verrucous vegetations affecting the mitral valve. No patient had haemodynamically significant clinical valve disease. Pericardial effusion was identified in 19 patients (27%), of whom 14 had mild and clinically silent disease. Myocardial abnormalities were found in 14 patients (20%), but clinical features of myocardial dysfunction were present in only one. Patients with antiphospholipid antibodies were found to have an increased prevalence of endocardial lesions, mainly valvular regurgitation. It is concluded that the inclusion of echocardiography in a study protocol of patients with SLE can identify an important subset of patients with cardiac abnormalities, many of which are clinically silent. In addition, the association of antiphospholipid antibodies with endocardial lesions suggests that these antibodies may have a prominent role in the pathogenetic mechanisms of heart valve disease in SLE.

Full text

PDF
156

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson D., Bell D., Lodge R., Grant E. Recurrent cerebral ischemia and mitral valve vegetation in a patient with antiphospholipid antibodies. J Rheumatol. 1987 Aug;14(4):839–841. [PubMed] [Google Scholar]
  2. Ansari A., Larson P. H., Bates H. D. Cardiovascular manifestations of systemic lupus erythematosus: current perspective. Prog Cardiovasc Dis. 1985 May-Jun;27(6):421–434. doi: 10.1016/0033-0620(85)90003-9. [DOI] [PubMed] [Google Scholar]
  3. Asherson R. A., Gibson D. G., Evans D. W., Baguley E., Hughes G. R. Diagnostic and therapeutic problems in two patients with antiphospholipid antibodies, heart valve lesions, and transient ischaemic attacks. Ann Rheum Dis. 1988 Nov;47(11):947–953. doi: 10.1136/ard.47.11.947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bulkley B. H., Roberts W. C. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients. Am J Med. 1975 Feb;58(2):243–264. doi: 10.1016/0002-9343(75)90575-6. [DOI] [PubMed] [Google Scholar]
  5. Cervera R., Font J., López-Soto A., Casals F., Pallarés L., Bové A., Ingelmo M., Urbano-Márquez A. Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients. Ann Rheum Dis. 1990 Feb;49(2):109–113. doi: 10.1136/ard.49.2.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cowchock S., Fort J., Munoz S., Norberg R., Maddrey W. False positive ELISA tests for anticardiolipin antibodies in sera from patients with repeated abortion, rheumatologic disorders and primary biliary cirrhosis: correlation with elevated polyclonal IgM and implications for patients with repeated abortion. Clin Exp Immunol. 1988 Aug;73(2):289–294. [PMC free article] [PubMed] [Google Scholar]
  7. DUBOIS E. L., TUFFANELLI D. L. CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES. JAMA. 1964 Oct 12;190:104–111. doi: 10.1001/jama.1964.03070150014003. [DOI] [PubMed] [Google Scholar]
  8. Doherty N. E., 3rd, Feldman G., Maurer G., Siegel R. J. Echocardiographic findings in systemic lupus erythematosus. Am J Cardiol. 1988 May 1;61(13):1144–1144. doi: 10.1016/0002-9149(88)90150-6. [DOI] [PubMed] [Google Scholar]
  9. Doherty N. E., Siegel R. J. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J. 1985 Dec;110(6):1257–1265. doi: 10.1016/0002-8703(85)90023-7. [DOI] [PubMed] [Google Scholar]
  10. Elkayam U., Weiss S., Laniado S. Pericardial effusion and mitral valve involvement in systemic lupus erythematosus. Echocardiographic study. Ann Rheum Dis. 1977 Aug;36(4):349–353. doi: 10.1136/ard.36.4.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Exner T., Rickard K. A., Kronenberg H. Studies on phospholipids in the action of a lupus coagulation inhibitor. Pathology. 1975 Oct;7(4):319–328. doi: 10.3109/00313027509081688. [DOI] [PubMed] [Google Scholar]
  12. Ford P. M., Ford S. E., Lillicrap D. P. Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus. J Rheumatol. 1988 Apr;15(4):597–600. [PubMed] [Google Scholar]
  13. Galve E., Candell-Riera J., Pigrau C., Permanyer-Miralda G., Garcia-Del-Castillo H., Soler-Soler J. Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. N Engl J Med. 1988 Sep 29;319(13):817–823. doi: 10.1056/NEJM198809293191302. [DOI] [PubMed] [Google Scholar]
  14. Gharavi A. E., Harris E. N., Asherson R. A., Hughes G. R. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis. 1987 Jan;46(1):1–6. doi: 10.1136/ard.46.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Harris E. N., Gharavi A. E., Boey M. L., Patel B. M., Mackworth-Young C. G., Loizou S., Hughes G. R. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. 1983 Nov 26;2(8361):1211–1214. doi: 10.1016/s0140-6736(83)91267-9. [DOI] [PubMed] [Google Scholar]
  16. Hughes G. R. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J (Clin Res Ed) 1983 Oct 15;287(6399):1088–1089. doi: 10.1136/bmj.287.6399.1088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Khamashta M. A., Harris E. N., Gharavi A. E., Derue G., Gil A., Vázquez J. J., Hughes G. R. Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes. Ann Rheum Dis. 1988 Oct;47(10):849–854. doi: 10.1136/ard.47.10.849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Klinkhoff A. V., Thompson C. R., Reid G. D., Tomlinson C. W. M-mode and two-dimensional echocardiographic abnormalities in systemic lupus erythematosus. JAMA. 1985 Jun 14;253(22):3273–3277. [PubMed] [Google Scholar]
  19. Lehman T. J., Palmeri S. T., Hastings C., Klippel J. H., Plotz P. H. Bacterial endocarditis complicating systemic lupus erythematosus. J Rheumatol. 1983 Aug;10(4):655–658. [PubMed] [Google Scholar]
  20. Lockshin M. D., Druzin M. L., Goei S., Qamar T., Magid M. S., Jovanovic L., Ferenc M. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med. 1985 Jul 18;313(3):152–156. doi: 10.1056/NEJM198507183130304. [DOI] [PubMed] [Google Scholar]
  21. Mandell B. F. Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum. 1987 Nov;17(2):126–141. doi: 10.1016/0049-0172(87)90035-7. [DOI] [PubMed] [Google Scholar]
  22. Moynihan T., Hansen R., Troup P., Olinger G. Simultaneous aortic and mitral valve replacement for lupus endocarditis: report of a case and review of the literature. J Thorac Cardiovasc Surg. 1988 Jan;95(1):142–145. [PubMed] [Google Scholar]
  23. Shapiro R. F., Gamble C. N., Wiesner K. B., Castles J. J., Wolf A. W., Hurley E. J., Salel A. F. Immunopathogenesis of Libman-Sacks endocarditis. Assessment by light and immunofluorescent microscopy in two patients. Ann Rheum Dis. 1977 Dec;36(6):508–516. doi: 10.1136/ard.36.6.508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Straaton K. V., Chatham W. W., Reveille J. D., Koopman W. J., Smith S. H. Clinically significant valvular heart disease in systemic lupus erythematosus. Am J Med. 1988 Nov;85(5):645–650. doi: 10.1016/s0002-9343(88)80236-5. [DOI] [PubMed] [Google Scholar]
  25. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES